Vericel (VCEL) Short-Term Debt repayments (2017 - 2018)
Vericel's Short-Term Debt repayments came in at $10,000 for Q1 2018, down 98.9% from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) Short-Term Debt repayments (2017 - 2018) Analysis & Trends
Over the trailing twelve months to Mar 31, 2018, Vericel reported Short-Term Debt repayments of $899,000; for FY2017, it came in at $889,000, down 63.0% from FY2016.
- Going back by year, Short-Term Debt repayments was $2.4 million in FY2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 6.45 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Vericel | 2.09 Bn | 1.51 Bn | 56.40 Mn | - |
API Access
Vericel Short-Term Debt repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt-repayments", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();